Senores Pharmaceuticals is Listed at a 53% Premium on NSE at ₹600 & on BSE at ₹593.7
Senores Pharmaceuticals’ shares debuted with a strong 53% premium, listing at ₹600 on the NSE and ₹593.70 on the BSE. The subscription status and Grey Market premium had pointed to strong listing gains following its public issue, which opened on December 20, 2024, and closed on December 24, 2024. Senores Pharmaceuticals IPO Subscription Status The … Read more